Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Gabriele Roccuzzo, Silvia Giordano, Paolo Fava, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20

Showing 20 citing articles:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 66
CCR4 as a Therapeutic Target for Cancer Immunotherapy
Osamu Yoshie
Cancers (2021) Vol. 13, Iss. 21, pp. 5542-5542
Open Access | Times Cited: 83
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies
Gabriele Roccuzzo, Giovenale Moirano, Paolo Fava, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 27-34
Closed Access | Times Cited: 32
Preliminary Experience in Ultra-High Frequency Ultrasound Assessment of Cutaneous Primary Lymphomas: An Innovative Classification
Anna Russo, Vittorio Patanè, Federico Gagliardi, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2456-2456
Open Access | Times Cited: 4
Understanding kidney involvement in mycosis fungoides: T-cell clonality as a guide for targeted therapy – a case report and literature review
Jelena Filipović, E. Maubec, Clelia Previtali, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
Jingjing Li, Xuan-Fu Xu
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1527-1540
Open Access | Times Cited: 9
Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice
Gabriele Roccuzzo, Luca Mastorino, Giuseppe Gallo, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 1899-1907
Open Access | Times Cited: 15
Advances in the pharmacological management of cutaneous T-cell lymphoma
Gabriele Roccuzzo, A Roggo, Egle Ramelyte, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 885-894
Closed Access | Times Cited: 2
Programmed Cell Death Protein 1 (PD-1) in Relation to PANoptosis: Immune Pharmacological Targets for Management of Breast Adenocarcinoma
Subarnarekha Maitra, Debarati Bhattacharya, Souvik Paul, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 23, Iss. 13, pp. 1571-1585
Closed Access | Times Cited: 6
The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, et al.
JCI Insight (2023) Vol. 8, Iss. 19
Open Access | Times Cited: 6
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin
Gabriele Roccuzzo, Paolo Fava, Gianluca Avallone, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 6, pp. 1019-1021
Open Access | Times Cited: 9
Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic
Gabriele Roccuzzo, Nicole Macagno, Cristina Sarda, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv40505-adv40505
Open Access | Times Cited: 1
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System
Gabriele Roccuzzo, Silvia Giordano, Gianluca Avallone, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 333-333
Open Access | Times Cited: 7
New and emerging therapies in cutaneous T-cell lymphoma
Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, et al.
Dermatology Reports (2024)
Open Access
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides
Mario L. Marques‐Piubelli, Jesús Navarrete, Debora Alejandra Ledesma, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 419-419
Open Access
Abrogation of USP9X Is a Potential Strategy to Decrease PEG10 Levels and Impede Tumor Progression in Cutaneous T-Cell Lymphoma
Shan Xiong, Fengjie Liu, Jingru Sun, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 12, pp. 2778-2788.e9
Closed Access
Chlormethine Gel Effectiveness as second-line Treatment in Mycosis fungoides: a single- centre Retrospective Study
Corrado Zengarini, Alba Guglielmo, Ludovica Vocale, et al.
Research Square (Research Square) (2024)
Closed Access
Inpatient Considerations in the Diagnosis and Management of the Cutaneous T-Cell Lymphoma Patient
Samantha Jakuboski, Thomas Doyle, Marianne Tawa, et al.
Current Dermatology Reports (2022) Vol. 11, Iss. 4, pp. 233-243
Closed Access | Times Cited: 1
Retinoid-associated myopia in dermatologic patients: a systematic review
Gabriele Roccuzzo, Tommaso Tibaldi, Francesco Cavallo, et al.
Cutaneous and Ocular Toxicology (2022) Vol. 41, Iss. 4, pp. 318-322
Closed Access | Times Cited: 1
Issue Highlights—May 2022
Bruno Brando
Cytometry Part B Clinical Cytometry (2022) Vol. 102, Iss. 3, pp. 185-188
Closed Access
Page 1

Scroll to top